Net Loss Per Share - Schedule of Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Options to purchase common stock | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of earnings per share (in shares) | 4,624,299 | 1,866,235 |
| Unvested restricted stock units | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of earnings per share (in shares) | 69,494 | 22,622 |
| Outstanding Parapyre warrants | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of earnings per share (in shares) | 1,532,591 | 1,532,591 |